Rufloxacin
| Code | Size | Price |
|---|
| TAR-T21035-5mg | 5mg | £1,010.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T21035-50mg | 50mg | £1,982.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T21035-100mg | 100mg | £2,560.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Rufloxacin is a drug that belongs to the class of fluoroquinolones, which act mainly as specific inhibitors of bacterial Topoisomerase II. These drugs involve in various diseases including cutaneous reactions, aging, etc.
CAS:
101363-10-4
Formula:
C17H18FN3O3S
Molecular Weight:
363.41
Purity:
0.98
SMILES:
CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O
References
1. Gismondo MR, Drago L, Lombardi A, Fassina C, Cesana M. Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model. Chemotherapy. 1995 Jul-Aug;41(4):281-8. PubMed PMID: 7555209.
2. Lazzaroni M, Imbimbo BP, Bargiggia S, Sangaletti O, Dal Bo L, Broccali G, Bianchi Porro G. Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. Antimicrob Agents Chemother. 1993 Oct;37(10):2212-6. PubMed PMID: 8257146; PubMed Central PMCID: PMC192252.
3. Gu LY, Lin WW, Lu H, Chen XY, Ge ZZ, Li XB. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study. Helicobacter. 2011 Aug;16(4):284-8. doi: 10.1111/j.1523-5378.2011.00848.x. PubMed PMID: 21762267.
4. Catalfo A, Scifo C, Stella S, Belvedere A, Renis M, De Guidi G. Rufloxacin induced photosensitization in bio-models of increasing complexity. Photochem Photobiol Sci. 2005 Mar;4(3):304-14. Epub 2005 Feb 2. PubMed PMID: 15739000.